Phil Franchina, Author at American Parkinson Disease Association

Making Hope Possible: American Parkinson Disease Association Supports Researchers With $2.6 Million in New Funding

Posted on September 5, 2024September 4, 2024 by Phil Franchina

Supports Researchers With $2.6 Million in New Funding From genetic causes of Parkinson’s to the neurobiology of cognitive dysfunction,...see more APDA-funded researchers begin new work. NEW YORK, NY, SEPTEMBER 4, 2024 – The American Parkinson Disease Association (APDA) has just awarded $2.6 million to support innovative Parkinson’s disease (PD) research for the 2024-2025 funding year – […]

Adaptive DBS – a new approach to improve PD symptoms

Posted on August 23, 2024May 28, 2025 by Phil Franchina

Deep brain stimulation (DBS) is a surgical procedure in which thin electrodes are implanted into parts of the brain...see more to alter brain circuitry. It is used in the treatment of several neurologic conditions including Parkinson’s disease (PD), in which the electricity disrupts abnormal brain signals that allows the brain to restore more normal movement. Currently, […]

Recently published research on induced pluripotent stem cells by APDA-funded researchers

Posted on August 12, 2024May 28, 2025 by Phil Franchina

APDA-funded researchers at Brigham and Women’s Hospital, including Drs. Isabel Lam and Anastasia Kuzkina, under the leadership of Dr. ...see more Vikram Khurana, the Director of APDA’s Center for Advanced Research at Brigham and Women’s Hospital, recently published a paper demonstrating a novel technology that more rapidly turns stem cells created from the cells of an adult […]

Crexont®: A Newly Approved Parkinson’s Medication

Posted on August 8, 2024October 10, 2024 by Phil Franchina

New Carbidopa/Levodopa Formulation Approved for Reducing OFF Time Amneal Pharmaceuticals, Inc. announced today that their new medication IPX203, now known as...see more Crexont®, was approved by the Food and Drug Administration. Crexont is a novel oral formulation of carbidopa-levodopa extended-release capsules. Similar to Amneal’s Rytary, it contains both immediate-release and extended-release elements in the capsule and is designed […]

VICTORY FOR THE PARKINSON’S DISEASE COMMUNITY: THE NATIONAL PLAN TO END PARKINSON’S ACT IS NOW LAW

Posted on July 22, 2024August 8, 2024 by Phil Franchina

It’s official: The...see more President has signed The National Plan to End Parkinson’s Act into law! This is a momentous event for the PD community — and APDA is proud to have been a part of the efforts that made […]

WHAT’S HAPPENING AT APDA

Posted on July 22, 2024August 8, 2024 by Phil Franchina

Join us for an Optimism Walk! We’ve got a fantastic fall schedule of APDA Optimism...see more Walks and would love for you to come walk with us! Every Optimism Walk is an incredible day of community, inspiration, and family-friendly fun, all directly supporting APDA’s mission. Whether you start a team, register on […]

LEGOS FOR PARKINSON’S

Posted on July 22, 2024July 22, 2024 by Phil Franchina

As part of the FIRST* LEGO® League program, a group of students (11–13-year-olds) from South Carolina...see more calling themselves the “Argent Agents” developed three tools out of Legos that make it easier for people with Parkinson’s disease and essential tremors to use a paint brush, pencil, or marker so they can create art. […]

“ASK THE DOCTOR” WITH DR. REBECCA GILBERT

Posted on July 22, 2024July 22, 2024 by Phil Franchina

Q: I always seem to be nauseous. Are there treatments for this?...see more A: Nausea can be a side effect of carbidopa/levodopa, the most common and effective medication for PD. If this is the case, then try taking the medication with food. Some people find that dietary protein such […]

THE RISE OF BIOMARKER TECHNOLOGY IN PARKINSON’S DISEASE

Posted on July 22, 2024July 22, 2024 by Phil Franchina

A biomarker is a clue inside the body that indicates that...see more disease is present. A biomarker can be an imaging test, a biopsy, or a test on a body fluid such as blood or cerebral spinal fluid. Recently, there has been an abundance of news about biomarkers […]

AMERICAN PARKINSON DISEASE ASSOCIATION CELEBRATES THE NATIONAL PLAN TO END PARKINSON’S ACT BECOMING LAW

Posted on July 3, 2024August 28, 2024 by Phil Franchina

APDA remains steadfast in its mission to support those impacted by Parkinson’s disease as new law provides hope for...see more accelerated progress toward a cure NEW YORK, NY, JULY 3, 2024 – The American Parkinson Disease Association (APDA) is celebrating the President’s signing of the National Plan to End Parkinson’s Act yesterday, marking the enactment of […]

What is Parkinson’s Disease?

Living with Parkinson’s Disease

Parkinson’s Resource Library

Research

Ways to Give

Making Hope Possible: American Parkinson Disease Association Supports Researchers With $2.6 Million in New Funding

Adaptive DBS – a new approach to improve PD symptoms

Recently published research on induced pluripotent stem cells by APDA-funded researchers

Crexont®: A Newly Approved Parkinson’s Medication

VICTORY FOR THE PARKINSON’S DISEASE COMMUNITY: THE NATIONAL PLAN TO END PARKINSON’S ACT IS NOW LAW

WHAT’S HAPPENING AT APDA

LEGOS FOR PARKINSON’S

“ASK THE DOCTOR” WITH DR. REBECCA GILBERT

THE RISE OF BIOMARKER TECHNOLOGY IN PARKINSON’S DISEASE

AMERICAN PARKINSON DISEASE ASSOCIATION CELEBRATES THE NATIONAL PLAN TO END PARKINSON’S ACT BECOMING LAW

Support Our Mission

Support Our Mission

Subscribe to get updates from APDA and helpful Parkinson’s info!